About this trial
Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
LBD diagnosis by a dementia or movement disorders specialist
Clinician-determined mild-moderate dementia severity
Internet access with a Zoom-compatible device
Caregiver who resides in the patient's home and is willing to participate
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Tele-neurohub
BehavioralInterdisciplinary care delivered using telemedicine (zoom) technology which includes neurologist, physical, occupational and speech therapy, social worker and dietician.
Treatment groups
Trial outcomes
Primary outcomes
Number of completed tele-health visits
Feasibility will be determined by completion of at least 75% telehealth visits by the intervention cohort
Secondary outcomes
Satisfaction assessed by Patient Assessment of Communication of Telehealth questionnaire.
Acceptability will be determined by at least 80% of dyads reporting being "satisfied" or "highly satisfied" on the Patient Assessment of Communication of Telehealth questionnaire.
Appropriateness assessed by Intervention Appropriateness Measure
Appropriateness will be determined by the Intervention Appropriateness Measure, higher scores indicate greater appropriateness
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Florida
Lead sponsor
National Institute on Aging (NIA)
Collaborator